Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male
1 other identifier
interventional
22
1 country
1
Brief Summary
This study examines the effect of 12-week strength training program with and without testosterone replacement therapy (TRT) on body composition, physical function, selected biochemical markers of metabolic health, molecular parameters of training adaptation and the quality of life patients with ADAM. The investigators believe, that strength training program performed 2 times per week for 12 weeks can improve body composition (decrease fat mass and gain lean mass), muscle strength, muscle power and general quality of life in all training groups. In addition, combination TRT and strength training could help decrease fat mass, improve BMI, cardio-respiratory fitness and thus provide optimal therapy combination for hypogonadal ageing males.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2017
CompletedFirst Posted
Study publicly available on registry
September 14, 2017
CompletedStudy Start
First participant enrolled
October 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2019
CompletedResults Posted
Study results publicly available
May 5, 2020
CompletedJuly 30, 2021
July 1, 2021
1.7 years
August 20, 2017
February 23, 2020
July 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change From Baseline in Lean Mass
Total body by Dual-energy X-ray Absorptiometry using Hologic fan-beam bone densitometer Discovery QDR series.
7 days before intervention, 7 days after intervention
Secondary Outcomes (19)
Change From Baseline in Fat Mass
7 days before intervention, 7 days after intervention
Change From Baseline in Total Body Mass
7 days before intervention, 7 days after intervention
Change From Baseline in 10-m Usual Walk Test
7 days before intervention, 7 days after intervention
Change From Baseline in 10-m Fast Walk Test
7 days before intervention, 7 days after intervention
Change From Baseline in Handgrip Strength
7 days before intervention, 7 days after intervention
- +14 more secondary outcomes
Study Arms (3)
hypogonadal males without TRT
EXPERIMENTALStrength training
hypogonadal males with TRT
EXPERIMENTALStrength training and regular prescribed testosterone therapy given by participant urologist.
healthy eugonadal males
ACTIVE COMPARATORStrength training
Interventions
The participants perform strength training sessions two times per week for 12 weeks. Each training session include 5-minute general dynamic warm-up followed by progressive strength training with exercises for the entire body. The strength exercises are performed with free weights and on machines. The training program consist of 6 exercises for upper and lower body at an intensity of 60-80% (8 - 12RM: the load that induces technique failure in eight or twelve repetitions) of one-repetition maximum and takes approximately 60 minutes. The exercises performed are: leg press, split squats, bench press, knee extension, knee flexion, seated cable rows, seated cable pull downs, dumbbell bench press, incline dumbbell bench press.
Eligibility Criteria
You may qualify if:
- Patients of secondary hypogonadism on testosterone replacement therapy, newly diagnosed patients of secondary hypogonadism.
You may not qualify if:
- Regular strength training, medical treating osteoporosis, abnormal digital rectal results, conditions which are medical contraindications (without adjusting state): diabetes mellitus, severe cardiac arrhythmia, uncontrolled hypertension, unstable angina pectoris, chronic obstructive pulmonary disease, epilepsy, unstable bone lesions with high risk of fracture, prostate cancer or abnormal serum PSA levels without adverse histological examination.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Comenius Universitylead
- Norwegian School of Sport Sciencescollaborator
- Slovak Academy of Sciencescollaborator
Study Sites (1)
Comenius University in Bratislava, Faculty of physical education and sport
Bratislava, 814 69, Slovakia
Related Publications (6)
Basaria S. Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth. J Androl. 2008 Sep-Oct;29(5):534-9. doi: 10.2164/jandrol.108.005454. Epub 2008 Jun 20.
PMID: 18567642RESULTHildreth KL, Barry DW, Moreau KL, Vande Griend J, Meacham RB, Nakamura T, Wolfe P, Kohrt WM, Ruscin JM, Kittelson J, Cress ME, Ballard R, Schwartz RS. Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels. J Clin Endocrinol Metab. 2013 May;98(5):1891-900. doi: 10.1210/jc.2013-2227. Epub 2013 Mar 26.
PMID: 23533227RESULTSchwarz ER, Willix RD Jr. Impact of a physician-supervised exercise-nutrition program with testosterone substitution in partial androgen-deficient middle-aged obese men. J Geriatr Cardiol. 2011 Dec;8(4):201-6. doi: 10.3724/SP.J.1263.2011.00201.
PMID: 22783306RESULTKadi F, Bonnerud P, Eriksson A, Thornell LE. The expression of androgen receptors in human neck and limb muscles: effects of training and self-administration of androgenic-anabolic steroids. Histochem Cell Biol. 2000 Jan;113(1):25-9. doi: 10.1007/s004180050003.
PMID: 10664066RESULTGardner JR, Livingston PM, Fraser SF. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol. 2014 Feb 1;32(4):335-46. doi: 10.1200/JCO.2013.49.5523. Epub 2013 Dec 16.
PMID: 24344218RESULTKralik M, Cvecka J, Buzgo G, Putala M, Ukropcova B, Ukropec J, Killinger Z, Payer J, Kollarik B, Bujdak P, Raastad T, Sedliak M. Strength training as a supplemental therapy for androgen deficiency of the aging male (ADAM): study protocol for a three-arm clinical trial. BMJ Open. 2019 Sep 5;9(9):e025991. doi: 10.1136/bmjopen-2018-025991.
PMID: 31492775DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
The major limit of the study was low number of the newly diagnosed patients.
Results Point of Contact
- Title
- Doc. Mgr. Milan Sedliak, PhD.
- Organization
- Comenius University in Bratislava
Study Officials
- PRINCIPAL INVESTIGATOR
Milan Sedliak, assoc. prof.
Comenius University of Bratislava, Faculty Physical Education and Sport
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Independent researcher, Vice-dean for science, research and international cooperation
Study Record Dates
First Submitted
August 20, 2017
First Posted
September 14, 2017
Study Start
October 1, 2017
Primary Completion
May 30, 2019
Study Completion
May 30, 2019
Last Updated
July 30, 2021
Results First Posted
May 5, 2020
Record last verified: 2021-07